TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

LONCASTUXIMAB 10 mg Powder for Soln for Infusion 1 Vial Box

Medical equipments
pharmaceuticals and personal care products
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: BELFAST HEALTH AND SOCIAL CARE TRUST: "LONCASTUXIMAB 10 mg Powder for Soln for Infusion 1 Vial Box". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityBELFAST HEALTH AND SOCIAL CARE TRUSTScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: BELFAST HEALTH AND SOCIAL CARE TRUST
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for BELFAST HEALTH AND SOCIAL CARE TRUST. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1Bids / Report
100% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 16 active published awards; 16 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published21 Aug 2024, 14:10 BST
Last source update21 Aug 2024, 14:10 BST
Recurring procurementNot published
ClassificationMedical equipments, pharmaceuticals and personal care products
OCIDocds-h6vhtk-049295
What is being bought
Procurement of LONCASTUXIMAB 10 mg Powder for Soln for Infusion 1 Vial Box
What changed
From the official release history
  1. Status changed to complete
    21 Aug 2024, 14:10 BST
  2. Official notice release published
    21 Aug 2024, 14:10 BST
  3. Buyer information updated
    21 Aug 2024, 14:10 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Procurement of LONCASTUXIMAB 10 mg Powder for Soln for Infusion 1 Vial Box
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    21 Aug 2024, 14:10 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 14 Aug 2024, 00:00 BST · £1,440,000
Commercial outcome and competition
Awards
ALLOGA UK LIMITED
Not published · Not published · active
Contracts
LONCASTUXIMAB 10 mg Powder for Soln for Infusion 1 Vial Box
£1,440,000 · signed 14 Aug 2024, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
Buyer and organisations in this procedure

BELFAST HEALTH AND SOCIAL CARE TRUST

Contracting authority GB-FTS-104485
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThese are branded patent protected medicines that are essential to patient care and are available from only one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement.